Over 2000 new job opportunities to clean up waterways | NZ Market Update

  • Jul 06, 2020 NZST
  • Team Kalkine

Comvita Limited (NZX:CVT) has hired Nigel Greenwood to take the position of Chief Financial Officer, in effect from September 15, 2020. He has worked for more than 10 years with Synlait Milk Limited (NZX:SML) as CFO, where he performed an influential role in increasing revenue from $100 million to $1 billion. Adrian Barr, the current acting CFO will assume the position of Chief Business Development Officer. He will be responsible for supervising the strategic assessment and development of crucial investments and commercial projects.

The government has announced a package of 23 projects across New Zealand to clean up waterways and these projects are expected to generate more than 2000 jobs. NZD 162 million packages will be distributed for 22 water clean-up schemes put forward by local councils getting NZD 62 million and Kaipara Moana Remediation Programme getting NZD 100 million to stop the degradation of the Kaipara harbour. The investment is a part of COVID-19 recovery plan and is funded from the NZD 1.1 billion Jobs for Nature package announced in Budget 2020 that is anticipated to create 11,000 environment jobs.

Metlifecare Limited (NZX:MET) had received a non-binding indicative offer from Asia Pacific Village Group Limited on Sunday 5th July 2020. The offer is to purchase all the shares of MET for $6.00 per share via a Scheme of Arrangement (NBIO). The Board members of the company have decided to engage with APVG in good faith to find out if the NBIO can be changed into a binding Scheme Implementation Agreement (SIA). The company has also advised shareholders to not to take any actions at this time.

#NZX #MET #CVT #Kalkine

 


Disclaimer
The video has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. The above video is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) under discussion. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site.

 

   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK